Neural Plasticity
Volume 2016 (2016), Article ID 5026713, 14 pages
http://dx.doi.org/10.1155/2016/5026713

Review Article

Gender Differences in the Neurobiology of Anxiety: Focus on Adult Hippocampal Neurogenesis

Alessandra Aparecida Marques,¹ Mário Cesar do Nascimento Bevilaqua,¹ Alberto Morais Pinto da Fonseca,² Antonio Egidio Nardi,¹ Sandrine Thuret,³ and Gisele Pereira Dias¹

¹Translational Neurobiology Unit, Laboratory of Panic and Respiration, Institute of Psychiatry, Universidade Federal do Rio de Janeiro, Avenida Venceslau Brás, 71 Fundos, Praia Vermelha, 22290-140 Rio de Janeiro, RJ, Brazil
²Physics Institute, Universidade Federal do Rio de Janeiro, Avenida Athos da Silveira Ramos, Cidade Universitária, 21941-916 Rio de Janeiro, RJ, Brazil
³Laboratory of Adult Neurogenesis and Mental Health, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London SE5 9RT, UK

Received 18 September 2015; Revised 30 November 2015; Accepted 6 December 2015

Academic Editor: Long-Jun Wu

Copyright © 2016 Alessandra Aparecida Marques et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Although the literature reports a higher incidence of anxiety disorders in women, the majority of basic research has focused on male rodents, thus resulting in a lack of knowledge on the neurobiology of anxiety in females. Bridging this gap is crucial for the design of effective translational interventions in women. One of the key brain mechanisms likely to regulate anxious behavior is adult hippocampal neurogenesis (AHN). This review paper aims to discuss the evidence on the differences between male and female rodents with regard to anxiety-related behavior and physiology, with a special focus on AHN. The differences between male and female physiologies are greatly influenced by hormonal differences. Gonadal hormones and their fluctuations during the estrous cycle have often been identified as agents responsible for sexual dimorphism in behavior and AHN. During sexual maturity, hormone levels fluctuate cyclically in females more than in males, increasing the stress response and the susceptibility to anxiety. It is therefore of great importance that future research investigates anxiety and other neurophysiological aspects in the female model, so that results can be more accurately applicable to the female population.

Dedicated to the memory of Dr. Anna Claudia Domingos da Silveira da Luz, whose efforts and dedication will always be a legacy for our lab

1. Introduction

Anxiety and fear are adaptive emotional reactions to both innate and conditioned stimuli perceived as dangerous. They have likely been conserved throughout evolution for their adaptive value in the survival of species by warning the individual of potential dangers through the triggering of a series of neurochemical, neuroendocrine, and behavioral responses. However, when these reactions become constant and intense, with prolonged or inadequate responses to neutral stimuli or even in the absence of stressors, it may be indicative of pathological anxiety [1, 2].

Anxiety disorders cause great suffering and loss of quality of life [3, 4]. A substantial literature suggests that women may be more vulnerable than men to developing anxiety [3–6]. Anxiety disorders are diagnosed at least twice as often in women than in men, and the prevalence in women increases with age, with the gradual decline of estrogen E2 secretion from the ovaries at menopause [7, 8]. Generalized anxiety disorder (GAD), for example, occurs in approximately 5% of the population; however, the incidence doubles in postmenopausal women [9].

At the neurobiological level, the basis of anxiety can be conceived of as a disruption in the fundamental mechanism of fight and flight responses regulated by the hypothalamic-pituitary-adrenal (HPA) axis. Fear and anxiety, therefore, involve brain structures participating in the regulation of the HPA axis, such as the amygdala, the hypothalamus, the periaqueductal grey, and the hippocampus [10]. Here, we highlight this latter structure and its remarkable ability to generate newly functional neurons throughout life, a phenomenon called adult hippocampal neurogenesis (AHN). Besides their well-known functions in regulating cognitive processes, these newly generated neurons have also been implicated in the regulation of fear and anxiety [11, 12] (Figure 1).

Figure 1: AHN is important for cognitive and emotional learning. The newly born neurons continuously generated in the postnatal hippocampus are believed to regulate cognitive and emotional tasks, as occurs in the contextual fear learning paradigm and the spatial learning assessed in the MWM. In contextual fear learning, the hippocampus is thought to be essential for the association between a previously neutral context and an aversive stimulus (in this case, a mild footshock) leading to a fear response (conditioned freezing) when the individual is reexposed to the context where the fear learning occurred. In the case of spatial learning, as assessed by the MWM, hippocampal cells are believed to play an important role in the cued spatial navigation strategies that make it possible for the rodent to more quickly find the hidden platform across the test trials. AHN = adult hippocampal neurogenesis; MWM = Morris water maze.

In addition, evidence suggests that both progesterone [13] and estrogens [14, 15] play an important role in enhancing the proliferation and survival of new neurons in the hippocampus of adult females, with ovariectomized (OVX) rats displaying impaired AHN [16]. Estrogens, particularly E2, play an important role in brain development, functioning, and aging; in addition, they exert important antioxidant [17], anxiolytic, and antidepressant-like effects [9, 18–20] besides modulating the dopaminergic [21, 22], serotonergic [23], and cholinergic neurotransmitter systems [24]. The cyclical nature of the secretion of estrogen until menopause, when women experience its almost total withdrawal, supports the role of hormones in gender differences and may contribute to the greater vulnerability of women to anxiety disorders at this age. However, in animal models, both at the behavioral and at the neurogenic levels males and females may respond differently, depending on the treatment, age, or exposure to stressors used, as will be seen in this review. This leads to a lack of a clear understanding on whether males and females display different neurogenic profiles either at baseline or under different experimental conditions. Such possible differences in neurogenesis could account at least in part for the differences in anxiety observed between genders in clinical practice. Therefore, considering the importance of understanding gender differences in the context of anxiety, so that more tailored interventions may be delineated for the women population, it is essential to discuss the evidence on the possible biological differences between males and females; here, a special focus is given to AHN and anxious behavior.

2. Neurobiology of Anxiety: Differences between Males and Females

Overall, women and men are physiologically very similar, except for the time, pace, and schedule of the production and secretion of certain hormones. Both genders are undifferentiated until the sixth week of gestation, when the testicles develop in males and the production of androgens begins, while in females a substantial increase in follicle stimulating hormones (FSH) takes place around 12 to 20 weeks. After this period, this process of sexual differentiation is terminated, and the hormonal environment of the brain is again very similar in males and females until puberty [7].

Estrogen is a crucial hormone for the regular functioning of the brain, and its exhaustion at menopause may contribute to the higher probability of development of pathological anxiety [25]. OVX rat models have been widely used to investigate the effects of reduced estrogen levels at menopause, although the fact that it induces a drastic decline in estrogen secretion, whereas at menopause this process occurs gradually, is an important limitation of the model. The aged rodent is another useful model, but less used for this purpose. Aged female mice have very low levels of E2 and experience increased anxiety that is associated with the decline in ovarian function [9].

Hormonal differences also play a role in levels of stress markers. Females present elevated HPA axis markers at both resting and stressed states [26], as well as higher baseline plasma corticosterone (CORT) levels in comparison to males [27]. In addition, greater CORT response has been demonstrated in females than males in some anxiety tests such as the elevated plus-maze (EPM) and the defensive prod-burying test even after treatment with diazepam [28].

Additionally, CORT levels in females are influenced by the estrous cycle peaking in the proestrus phase and declining during the estrous phase, which at least partly explains why males and females respond differently to stressful situations [29] (for more details on the estrous cycle, please see Box 1).

The estrous cycle consists of the reproductive cycle of females. It lasts four to five days

and is divided into four phases: proestrus, estrous, metaestrus, and diestrus [103]. It can be

identified by cytological analysis according to the proportion and cell types in the

vaginal secretion [104].

Each phase of the cycle lasts around 24 hours and is mainly linked to fluctuations in

estradiol levels, which begins at puberty and ends in senescence (about 12 months in

female rats). The metaestrus and diestrus phases have low level concentrations of serum

estradiol. The proestrus is characterized by the highest level of estradiol followed by the

estrous phase, where levels of the hormone start to decrease, coinciding with ovulation

and corpus luteum formation [105].

Box 1: Estrous cycle.

Although clearly important, the influence of sex hormones is not the only mechanism involved in the development of sexual dimorphism. Genetic mechanisms, regardless of hormone action, may trigger the sexual differentiation of the brain and behavior [5]. The environment also appears to have an important impact on the dimorphism and differentiation of the central nervous system (CNS), thus also affecting behavior [5, 30]. In addition, sex differences in AHN (as will be later discussed) can also differently influence sexual dimorphisms.

Growing evidence also points to a role of gastrointestinal (GI) activity in leading to differential behavioral and neuroendocrine changes in males and females. Research data show that gastric inflammation induced by iodoacetamide (IAA) leads to anxiety behavior in female rats by a neuroendocrine pathway (the HPA axis), but not in male rats [27]. The reduction in circulating CORT, in the mRNA expression of glucocorticoid receptors (GR), and the increase in corticotrophin-releasing factor (CRF) mRNA in the hypothalamus of IAA-treated females suggest that GI activity has a gender impact on the HPA axis, being associated with its hyperactivity in females. This hyperactivity, in turn, is likely due to different sensitivities in the negative feedback of the HPA axis by CORT [27].

Gender differences were also found in the maternal separation model in rats, where separation during the lactation period resulted in decreased anxiety in females in comparison to males, despite the decreased expression of gamma-aminobutyric acid- (GABA-) A receptors in both sexes [31].

Significant gender differences were also reported in the prelimbic (PL) cortex activity during fear extinction and extinction recall [32]. Males presented PL activity decreased in the safe context, while females displayed increased PL activity in the same context; however, both showed increased infralimbic (IL) cortex activity before extinction recall compared to before extinction. These results suggest that female rats show increased expression of learned fear involving the persistent activation of PL.

According to the authors, this result may be related to possible disruptions in hippocampal connectivity to the PL, considering the role of the hippocampus in mediating contextual processing. In particular, the input of the ventral hippocampus (VH) to PL appears to be linked to the regulation of the extinction process [33]. In this sense, it has been shown that the temporary inactivation of the VH increases PL activity and expression of learned fear after extinction [34]. The authors highlight that females could therefore display changes in hippocampal-mediated inhibition of mPFC function, in agreement with findings in female patients with posttraumatic stress disorder (PTSD) [32, 35]. Furthermore, anxiety has been linked with impaired hippocampal neurogenesis [12], raising the possibility that altered AHN could also participate in the regulation of the fear circuitry. Whether this could be related to differential rates of AHN between males and females is a question that will be further discussed next.

2.1. Adult Hippocampal Neurogenesis and Anxiety

Adult neurogenesis, a phenomenon first described by Altman during the 60s [36], refers to a mechanism of continuous formation of newly functional neurons throughout life, a process that takes place only in specific regions of the adult brain [37].

In this regard, although also identified in structures such as the hypothalamus and the amygdala [38], neurogenic niches in the adult brain are mainly considered to reside in the dentate gyrus (DG) of the hippocampus and the subventricular zone (SVZ) adjacent to the lateral ventricles [39, 40].

Due to its influence on mental health-related behaviors, including anxiety, we will focus this review on hippocampal neurogenesis.

The hippocampus is a region extremely sensitive to stress, and neurogenesis has been proposed to be linked to the development of pathological anxiety [41]. Growing evidence supports this idea, as chronic stress has been shown to reduce hippocampal neurogenesis, besides changing the activity of the HPA axis, thereby undermining the ability of the hippocampus to modulate the brain areas involved in stress and anxiety responses [42, 43].

AHN is a dynamic and highly regulated process, comprised of the stages of proliferation, differentiation, migration, integration, and survival [37, 40]. The subgranular zone (SGZ) of the DG is known to contain a large number of neural progenitor cells (NPCs) that retain the ability to divide resulting in cells that have the potential to become mature granule cells [44]. Proliferation is an expansion of the pool of NPCs, followed by a selection process where about half of these new cells will undergo apoptosis [45], while the surviving neuroblasts migrate into the granular zone of the DG [46]. Mice studies have shown that around four weeks these new cells already begin to express neuronal markers and are functionally incorporated into the preexisting circuit [47].

This mechanism of generation of new neurons can be affected by external stimuli, such as learning and memory [48], exercise [49], diet [50], environment [51], stress [52], and aging [53], as well as pharmacological agents [54] and internal stimuli. Among the internal stimuli known to upregulate the AHN process, we can highlight the microenvironmental factors, such as trophic factors [55], growth factors [56], increased vasculature [48], chemical and electrical changes such as excitatory stimuli [57, 58], and gonadal hormones (estradiol in females and testosterone in males) [59]. Moreover, there are also microenvironmental factors that negatively regulate this process, such as immune responses [60], glucocorticoids [42], and physiological changes associated with aging [61].

In addition, recent studies have attributed to AHN a regulatory role in various cognitive processes such as memory [42, 62], learning [61, 63, 64], besides a significant influence on affective disorders [65], anxiety [12], and emotional behavior [66]. Evidence for the role of AHN in the regulation of learning and memory is based on electrophysiological findings showing that new neurons in the hippocampus exhibit enhanced long-term potentiation (LTP), an important cellular mechanism underlying learning processes and memory [67]. In accordance with this, studies have shown that ablation of neurogenesis using genetic manipulation or irradiation techniques results in behavioral changes, such as cognitive deficits [68], including impaired performance acquired in the water maze by runners mice [69].

Despite the classic role attributed to the hippocampus and AHN on cognition, several researchers have suggested a link between neurogenesis and anxiety-related behaviors. One of the most convincing studies demonstrating this association was published by Revest et al. [12]. In this study, the authors used an inducible transgenic strategy that enabled the specific ablation of newborn neurons in the adult DG to demonstrate that deficits in hippocampal neurogenesis lead to an increase in anxious behavior. Furthermore, Dias and colleagues have found a decreased number of immature neurons in the DG of a rodent model for the study of generalized anxiety [70]. In addition, it has been suggested that the birth of new neurons in the hippocampus may be involved in the ability of the DG to distinguish contexts, and deficits in this ability could be an important factor in the etiology of anxiety disorders [11, 71]. The promotion of AHN has therefore been discussed as a potential target for the treatment of anxiety disorders [65, 71, 72].

2.2. Adult Hippocampal Neurogenesis: Differences between Males and Females

The differences between sexes with regard to AHN are derived largely from the singular physiology of females that allows pregnancy, parturition, and lactation [73]. This particular physiology makes females undergo profound hormonal changes throughout life. In addition, hormonal fluctuations experienced by females during biological processes such as the estrous cycle, pregnancy, and maternity are associated with a number of changes in the brain and behavior [74].

Gonadal hormones, besides exerting a powerful anxiolytic role, are also known by their effects in directly affecting hippocampal neurogenesis in females, via regulation of the proliferation and survival of new neurons [59]. This effect is possible due to the presence of estrogen receptors, ERβ and ERα in the DG [59, 75]. Evidence has shown that both ERα and ERβ receptors are involved in the improvement of AHN in rats [26, 76]. However, ERβ agonists result in a greater neurogenic response, suggesting that ERβ may be more strongly associated with AHN than ERα [75]. Conversely, the ER antagonist ICI 182,780 could partially block the rise in estradiol-induced cell proliferation in the DG of rats [38]. Luteinizing hormone (LH), known for its important role during pregnancy and sexual behavior, also exerts influence on neurogenesis in females. Studies have shown that exposure of females to male pheromone or subcutaneous administration of a high dose of LH induced increased proliferation of new neurons both in the SVZ and in the DG [77]. Induced sexual experience was also reported to increase neurogenesis and reduce anxiety in females [78].

Although other female gonadal hormones like progesterone [73, 79] and LH [77] can also lead to improvements in AHN, estrogens are the most widely studied class of gonadal hormones, especially estradiol, the most potent form of estrogen [75]. Several articles have shown significant increases in the proliferation and survival of newly born neurons in the hippocampus after treatment with estradiol [13, 59, 73, 76, 80, 81], but not with other estrogens, such as estrone [14, 75]. In addition, during the proestrus phase of the estrous cycle, where estradiol levels are higher, rats exhibit about 50% higher proliferation than rats during diestrus and estrus stages when estradiol is low [82]. In OVX rats, proliferation of new neurons is significantly reduced, while estrogen replacement reverses the effect of ovariectomy [38, 83]. Additionally, another study has shown increased proliferation of new DG cells in OVX rats after estradiol injection or addition of soy extract in drinking water [84]. Furthermore, estrogen can also mediate AHN via growth factors and/or neurotransmitter systems.

Evidence suggests that estrogen regulates the expression of BDNF which in turn promotes the survival of newborn neurons in the hippocampus [85]. Moreover, it is known that estrogen plays an important role in modulating the levels of serotonin (5-hydroxytryptamine; 5-HT) synthesis via the regulation of tryptophan hydroxylase [74]. It has been shown that an increase in 5-HT in the DG increases cell proliferation while a reduction of 5-HT reduces proliferative activity [38]. In addition, serotonin antagonists can block the effect of estradiol to enhance cell proliferation [59, 86]. Also, it is well established that animal models of anxiety have exaggerated HPA axis responses to stress. In this context, it has been shown that E2 administration to rats with low endogenous levels of this hormone can alter this response, but its effects are previous experience- and regimen-dependent [9].

Estrogen levels have, therefore, been positively correlated with cell proliferation and negatively correlated with cell death [83]. During pregnancy and postpartum period, for example, estrogen is related with an increase of neuroplasticity [83]. During the proestrus phase, which is characterized by high levels of circulating estrogen, females exhibit greater cell proliferation in the DG than males, or females during the other phases of the estrous cycle [87, 88]. Moreover, several studies have shown that females and males respond differently to gonadal hormones administration in the context of hippocampal neurogenesis (see Table 1).

Table 1: Differences between males and females with regard to AHN.

Model
Intervention/behavioral paradigm
Differences in AHN between males and females
Differences in anxious behavior between males and females
Differences in other types of behavior between males and females
Reference

PND70–90 Sprague-Dawley rats
Eyeblink conditioning
Twice more new cells (mainly neuroblasts) survived in the female than in the male hippocampus
—
Females learned to time the conditioned response faster than males
[63]

380 g (male) and 240 g (female) Wistar rats
Exposure to stressors
↑ proliferation in the DG of females compared to males; ↑ DCX in the DG of males compared to females
—
Females showed ↑ basal and stress-induced HPA axis activity compared to males
[87]

PND80–90 Sprague-Dawley rats
Treatment with E2 or sesame oil
↑ proliferation, ↓ cell death, and ↓ survival in the DG of females; males were affected minimally
—
Female rats froze less than males after contextual fear conditioning
[106]

PND80–90 Sprague-Dawley rats
Treatment with E2 benzoate
↓ survival, ↑ proliferation, ↓ cell death in the DG of females, and no effect in males
—
—
[80]

3-month-old Wistar rats
Chronic stress
↓ BrdU labelling in males, but ↑ in females
—
—
[82]

250–300 g Sprague-Dawley rats
Acute stress (exposure to a predator odor)
↓ proliferation, ↓ cell death in males but not in females
—
—
[95]

PND58–62 Sprague-Dawley rats
Spatial task
↑ BrdU-labeled cells in males, ↑ cell activation in females but not in males
—
Males performed better in the spatial but not cue task than females
[107]

2-3-month-old Sprague-Dawley rats
Acute stress
↓ proliferation in male hippocampus but not in female
—
Exposure to stress significantly ↓ learning ability in females but ↑ in males; males expressed more helplessness behavior than females
[94]

2-3-month-old Swiss CD1 mice
Treatment with MXC
↑ survival in males compared to females

Male mice exhibited ↓ contextual conditioned freezing compared to females
[91]

3-month-old Sprague-Dawley rats
PRS
↓ number of new neurons in the DG and ↑ BDNF levels in males but not in females
Males showed ↑ anxiety, while females displayed ↓ anxiety in the EPM
—
[93]

PND63–65; PND24–26 (peripubescent) Sprague-Dawley rats
Fluoxetine treatment
↑ cell proliferation in males but not in females
↓ cell survival in females but not in males
—
—
[97]

C57Bl/6J mice
ES (limited nesting/bedding material)
↓ cell survival only in males
—
Males showed impaired cognitive performance in the ORT, OLT, and MWM, compared to females
[100]

AHN = adult hippocampal neurogenesis; BDNF = brain-derived neurotrophic factor; BrdU = bromodeoxyuridine; DG = dentate gyrus; DHT = dihydrotestosterone; DCX = doublecortin; EPM = elevated plus maze; ES = early life stress; E2 = estradiol; MXC = methoxychlor (organochlorine insecticide); PND = postnatal day; PRS = prenatal restraint stress; SVZ = subventricular zone; T = testosterone; ES = early life stress; ORT = object recognition task; OLT = object location task; MWM = Morris water maze.

Treatment with estradiol or estradiol benzoate produced different behavioral effects in both genders [80, 89]. With regard to neurogenesis, females after estradiol benzoate treatment exhibited an increase in cell proliferation, and a decrease in both overall cell death and neuron survival in the DG, but males are minimally affected [80]. On the other hand, males injected with estradiol for 30 days presented no change in neurogenesis; however, they showed significant increased AHN via cell survival after treatment with both testosterone and dihydrotestosterone (DHT), one of the main metabolites of testosterone [90]. In addition, rats treated with the organochlorine insecticide methoxychlor (MXC), a synthetic compound known for their xenoestrogens properties able to cause disruption of the endocrine system, exhibited higher density of surviving cells in males than in females [91].

Sex differences in regard to AHN with respect to the stress response have also been widely reported. Exposure to stress increases levels of glucocorticoids, and when occurring during the prenatal period, this increase can cause substantial changes in neuroplasticity, reducing the capacity for cell proliferation in adults [92]. Accordingly, analysis of the brain tissue of adult rats whose dams were subjected to restraint stress 3 times per day during the last 10 days of pregnancy showed decreased survival of new neurons in the DG and increases of hippocampal BDNF levels in males, but not in females [93]. Besides, the type of stress and the duration (whether acute or chronic) are also an important factor in influencing AHN. Both acute stress caused by foot-shock [94] as caused by acute exposure to a predator odor have been reported to be associated with reduced cell proliferation in the male, but not in the female hippocampus [95]. Conversely, individually housed female rats which underwent chronic stress (daily foot-shocks for 3 weeks) showed increased BrdU labeling in comparison to males [82].

The age of animals is another relevant variable for the understanding of gender differences in the context of AHN. Postnatal neurogenesis during puberty occurs in young animals (between postnatal days (PND) 21 and 28; PND21–28) who have not yet reached sexual maturity [96]. Investigations of neurogenesis at this stage of development are important for the understanding of the mechanisms underlying neurogenesis and evaluation of their possible changes and particularities throughout life. Hodes et al. compared the effects of chronic fluoxetine treatment in adult and peripubescent rats of both sexes and found an increase in cell proliferation in adult males but not in adolescent males or females, as well as reduced cell survival in females but not in males [97]. Investigations about the effects of maternal deprivation in rats in early life reported increased proliferation in the DG in males and decreased in females at PND21 [98]. However, in an experiment in which male mice were subjected to early life stress (maternal separation) it was found that rats tested during peripubescence (PND21) exhibited increased neurogenesis, whereas when tested during adulthood (2 months old) no differences were found, and at middle-age (15 months old) AHN was decreased [99]. Moreover, using a different type of early life stressor (limited nesting and bedding material from PND2–9), Naninck and colleagues showed that both sexes exhibited significantly increased proliferation at PND9, but in adulthood males presented reduced long-term survival of newly generated cells, while females were not affected [100].

The effects of early life stress thus appear to be sex- and age-dependent, with different responses depending on the age at which the hippocampus is under analysis. Increased neurogenesis in young rodents which were subject to early stress may be explained as a compensatory mechanism enabling the survival of the organism under adverse conditions. However, this early improvement is not always observed in females. In addition, it may be interesting to note that the decreased neurogenesis reported in some studies in females using early life stress occurs during a critical period of brain development, which could increase the vulnerability of females to the development of psychiatric disorders such as depression [101], a condition often found to be comorbid with anxiety. A reduction in hippocampal volume in women who experienced early childhood trauma has been reported, suggesting that stress early in life can alter the structure and function of the hippocampus in humans also [102]. Whether this reduced hippocampal volume is also associated with reductions in AHN is a question yet to be investigated.

3. Potential Interventions for the Enhancement of AHN and Alleviation of Anxiety

Several external factors can induce physiological changes in the organism, thus exerting influence over AHN rates [38, 108, 109]. Based on this knowledge, different interventions have been proposed as possible enhancers of this mechanism [9, 38, 45, 110]. Here, we highlight some of them as possible ways to help overcome anxious symptoms, although it is clear that further studies are needed in order not only to clarify the participation of AHN as a pivotal mechanism underlying the higher anxiety observed in the women population but also to ascertain the effectiveness of these interventions among females.

Exercise is cited as one of the most powerful stimulants of neurogenesis [111–114]. It is believed that this effect is due to the increased oxygenation, metabolism, and blood flow favored by exercise, which could result in an increased nutrient delivery, providing increased synthesis and release of growth factors, such as brain-derived neurotrophic factor (BDNF), and neurotransmitters [115–117]. Furthermore, physical exercise has been reported to reduce anxiety. Corroborating this idea, studies have shown that voluntary wheel running produced anxiolytic effects in rats and mice [118–120], while the cessation of voluntary wheel running increased anxiety and impacted AHN negatively [121]. This strongly indicates that the improvement of neurogenesis afforded by exercise is associated with reduced anxious symptoms [121], although excessive physical exercise, at least in male mice, has been shown to improve neurogenesis but also anxiety-like behavior [122]. Furthermore, depending on the context, voluntary exercise can accentuate anxiety in females, as is the case with treatment with androgenic anabolic steroids [123]. Further studies are therefore needed in order to unravel the optimal conditions where females can benefit from physical exercise as an intervention to reduce anxiety.

Another factor with great positive impact over AHN is diet. Dietary interventions can comprise nutrient content, quantity, frequency, and texture [50, 124, 125]. Caloric restriction (CR), for instance, has been cited as an effective intervention in the expansion of neurogenesis [50]. Studies showed that CR rats displayed an increase in AHN rates when compared to animals fed ad libitum [126]. In addition, CR is also aimed to improve some cognitive processes generally impaired in anxious patients, such as fear extinction learning and retention [127]. As shown by Riddle and colleagues, after CR treatment for 7 days, significant effects on the enhancement of fear extinction and retention were found only in females but not in male mice [127].

Also pointing for anxiolytic properties of CR, a study showed that male rats under a 25% CR regimen entered more in the open arms of the EPM and spent more time in the center of the arena in the open-field test (OFT), indicating reduced anxiety [128].

With respect to the frequency of food intake, studies in rodents subjected to intermittent fasting (IF), where animals are fed on alternate days, also showed improvement in brain plasticity by increasing the survival of new neurons generated [129] as well as improvement in the ability to integrate and consolidate information compared to mice fed ad libitum [130]. However, the literature still lacks data on mechanisms underlying the effects of IF specifically in females and its possible role in anxiety disorders. Further studies are therefore required for a deeper understanding of this intervention, especially in the female population.

With regard to the quality of nutrients, some of the beneficial compounds more thoroughly investigated as brain plasticity enhancers are the polyphenols and the n-3 polyunsaturated acids (PUFA). Polyphenols (such as curcumin and resveratrol) are bioactive compounds found in a number of plants and spices present in the human diet, such as turmeric (in the case of curcumin) and red berries, the skin of red grapes, red wine, and nuts (in the case of resveratrol). These compounds are known for their neuroprotective and antioxidants actions [131] in addition to their anxiolytic and antidepressant properties [110, 132]. The improvement of AHN as a result of polyphenolic treatment has been shown both in vitro and in vivo, with curcumin-treated mice exhibiting increased cell differentiation [133].

OVX rat models have been used to investigate the protective role of grape powder on anxiety in estrogen-deficient females. OVX rats treated with grape powder for 3 weeks showed decreased anxiety [134]. In addition, a study in OVX mice suggested that resveratrol could act as an ER agonist mimicking the effects of estrogen [135], which potentially could be used as a safe alternative to protect the brain against the effects of estrogen deficits that occur in menopause.

As well as treatment with polyphenols, the consumption of foods rich in PUFAs has also been shown to exert positive effects on neurogenesis. A study by Venna et al. found an increase in cell proliferation in the DG after 5 and 6 weeks of PUFA supplementation [131], highlighting the important role of diet in brain plasticity, and AHN in particular.

A number of studies have suggested that an enriched environment (EE) is a promising intervention for the improvement of AHN [136–138]. EE consists of a larger habitat where animals are housed in groups so that social interaction is facilitated. This environment is also characterized by the presence of stimulating toys, tunnels, and platforms. These stimuli are changed regularly in order to promote curiosity and exploration, as well as to provide sensorial experience, and motor and cognitive stimulation to the animals. With regard to AHN, a study by Leal-Galicia et al. showed increased proliferation, survival, and differentiation of new neurons in the DG of rats submitted to EE, as well as reduced anxiety in several behavioral tests accompanied by higher rates of BrdU positive-cells in the hippocampus of animals with a reduced anxiety response [139]. In accordance with these findings, several studies have found an improvement in neuroplasticity accompanied by reduced anxiety in rodents subjected to EE paradigm [140–142]. However, findings suggest that the duration of exposure to an EE seems to influence anxiety-like behaviors. For example, reduced anxiety in the EPM was observed in mice exposed to an EE for 3 weeks, but not in the group exposed for 24 hours, 1 week or in animals subjected to more prolonged periods of exposure, such as five weeks [143]. However, not all these interventional studies were undertaken with female rodents. This highlights the need for future investigations into the effects of these potential interventions on reducing anxiety-like behavior in this population both in AHN-dependent and independent manners.

Another possible category of intervention could be hormonal therapy. E2-based therapies have been used for many years to treat physiological symptoms associated with menopause such as hot flushes, sweating, genital dryness, and mental symptoms, such as cognitive deficits and increased anxiety [20]. Several studies in menopausal women have shown that E2 replacement therapy attenuates the loss of cognitive performance associated with the end of the reproductive cycle [9]. Women who received E2 after menopause demonstrate verbal improvement, and improvement in short and long-term memory, as well as logical reasoning, compared to controls [144, 145]. In animal models, it has been shown that cognitive deficits related to reduction of circulating E2 levels after menopause coincided with the reduction of cell proliferation in the hippocampus [83]. On the other hand, increasing levels of estradiol have been suggested to improve neurogenesis and cognitive aspects. As shown by a study by Frye et al., E2 administration to mice reverses the cognitive deficits caused by aging, significantly improving spatial learning performance and reference memory in the water maze task [146].

However, the limitations of hormone replacement therapies due to their proliferative effects on breast and uterus curbed the enthusiasm of the use of E2 as treatments for anxiety disorders [147]. Moreover, not all individuals respond favorably to E2. Some women with anxiety disorders report less anxiety when E2 levels are low and/or relatively stable, which suggests that some individuals may be more sensitive than others to E2 [9, 148]. For these individuals, other strategies such as diet based on phytoestrogens, compounds present, for example, in soy extract with weak estrogenic or antiestrogenic activity, might be useful considering their neuroprotective effect, and their ability to increase the production of new cells in the hippocampus [84]. Another phytoestrogen, α-zearalanol (α-ZAL), has been used as a safe alternative for estrogen, due to reduced side effects on the uterus and breast. Studies showed that both α-ZAL and 17β-E2 improved neurogenesis and learning and memory deficits [149].

Data from a recent study, though, showed that treatment with 10b, 17b-dihydroxyestra-1,4-dien-3-one (DHED) was effective in reducing symptoms associated with estrogen deficits in the brain and in promoting neuroprotective effects in rats [150]. These are promising findings, considering that DHED is a small-molecule bioprecursor prodrug which is converted to 17b-estradiol in the brain but remains inactive in the rest of the body. This, therefore, prevents the adverse side effects normally found in the periphery and for which reason estrogen replacement therapies cannot be used safely.

Besides, as previously discussed, it could be hypothesized that cases unresponsive to E2 could still benefit from other practices such as those related to diet, exercise, and a stimulating environment. Novel studies are, however, still needed to assess their efficacy in terms of onset, duration, and synergistic effects with other interventions and conditions in humans, with a special focus here on the female population.

4. Discussion

Animal models can help to elucidate some aspects of neuropsychiatric disorders, but their establishment implies some important principles. Behavioral models can be appropriate for one sex and inappropriate for another, and generalizations on the findings in one sex to another seem to be a biased process at best. Therefore, caution is needed when interpreting data, as it may be possible that certain behavioral paradigms and interventions are not interchangeable in males and females [5]. In addition to behavioral differences, there are outstanding physiological differences between genders, as indicated throughout the paper. The reproductive process results in important functional changes in the female brain, mainly due to gonadal hormones. AHN, for example, is regulated in females and males by both gonadal and adrenal hormones, but are sex- and experience-dependent [73]. This shows that it cannot be affirmed that males and females have each a certain established neurogenic profile, as this changes in accordance with a number of variables. Moreover, results of behavioral or physiological analysis in females depend on the stage of the estrous cycle, that is, the hormone levels that are circulating at that moment [83, 89]. Finally, there is a very small number of studies in the literature assessing gender differences in behavioral tests of anxiety. Therefore, the hypothesis raised in this review will only be fully answered by future studies on the possible mechanisms underlying the gender gap with regard to stress or threat responses, as well as using AHN markers as one of their neurobiological readouts. These will be an invaluable source to help us better understand the differential vulnerability for mood and anxiety disorders between men and women [7].

Clinical studies showed that due to the sudden drop of estradiol levels that occurs during pregnancy, postpartum women have a higher reactivity of the HPA axis to stressors [27, 151]. Furthermore, estradiol is pointed to modulate neurotransmission, synaptic plasticity, and neurogenesis [75, 152], besides cognitive functions and emotional responses through the hippocampus, a structure known as one of the key regions of the so-called emotional brain due to its role in modulating anxiety states [12, 153]. There is growing evidence showing that deficits in neurogenesis are related to increased anxiety-like behavior [12, 154–157]; on that account, investigating the mechanisms of action and effects of E2 on the modulation of AHN and anxiety disorders has become a goal of potentially great importance and clinical impact. In recent years, a significant increase in life expectancy of women has been observed; however, the age of onset of menopause has remained relatively constant, resulting in a larger portion of life, about one-third, where women live with low endogenous levels of E2. It is therefore likely that more women make use of therapies based on E2 to relieve symptoms of menopause, necessitating an intensification of research into the possible benefits and risks of hormone replacement therapy [20, 32, 158].

Functional neuroimaging techniques also appear to be a promising tool to reveal the neural mechanisms underlying anxiety disorders, leading to the development of more effective therapeutic options, as they can help us understand how new pharmacological treatment options may work and predict if the patient is likely to respond to a particular intervention or not [159]. Despite the extensive amount of research in animals, little is known about the mechanisms of neurogenesis in the adult human brain, which is limited by postmortem histological studies [160, 161]. Thus, the future development of more sensitive and specific techniques of molecular neuroimaging for the investigation of human AHN is of great importance, as they hold unprecedented potential for the design of more effective treatment, with less side effects and improved life expectancy and quality of life.

5. Conclusion

Consistent evidence in the literature points to important differences between males and females with regard to anxious behavior and a number of biological mechanisms, including AHN, with different interventions bringing both sex- and age-dependent differential regulation of the ability of the hippocampus to generate newly functional neurons throughout life. As a whole, studies with animal models support the overall idea that increased levels of AHN are associated with decreased levels of cognitive deficits and anxiety. Therefore, interventions that are able to promote AHN are hypothesized as potentially effective to improve anxiety-like behavior, although further testing in female rodents and in the human population at different ages is still needed.

Of special note, disrupted levels of estrogen at menopause may contribute to the development of pathological anxiety. In addition, with increasing life expectancy, it is likely that more women will make use of estrogen-based therapies to relieve symptoms of menopause, making it necessary that research in females be undertaken into the possible benefits and risks of hormone replacement therapy, as well as on interventions that may enhance AHN and alleviate symptoms of anxiety.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors also would like to thank the grants provided by the Brazilian Council for Scientific and Technological Development (CNPq) and Carlos Chagas Filho Research Support Foundation (FAPERJ).

References

C. Gross and R. Hen, “The developmental origins of anxiety,” Nature Reviews Neuroscience, vol. 5, no. 7, pp. 545–552, 2004.

G. P. Dias, M. C. D. N. Bevilaqua, A. C. D. Silveira, J. Landeira-Fernandez, and P. F. Gardino, “Behavioral profile and dorsal hippocampal cells in carioca high-conditioned freezing rats,” Behavioural Brain Research, vol. 205, no. 2, pp. 342–348, 2009.

V. B. Risbrough and M. B. Stein, “Role of corticotropin releasing factor in anxiety disorders: a translational research perspective,” Hormones and Behavior, vol. 50, no. 4, pp. 550–561, 2006.

A. R. Hariri, E. M. Drabant, K. E. Munoz et al., “A susceptibility gene for affective disorders and the response of the human amygdala,” Archives of General Psychiatry, vol. 62, no. 2, pp. 146–152, 2005.

P. Palanza, “Animal models of anxiety and depression: how are females different?” Neuroscience and Biobehavioral Reviews, vol. 25, no. 3, pp. 219–233, 2001.

B. Zimmerberg and M. J. Farley, “Sex differences in anxiety behavior in rats: role of gonadal hormones,” Physiology and Behavior, vol. 54, no. 6, pp. 1119–1124, 1993.

M. V. Seeman, “Psychopathology in women and men: focus on female hormones,” The American Journal of Psychiatry, vol. 154, no. 12, pp. 1641–1647, 1997.

D. J. Nutt, H.-U. Wittchen, J. C. Ballenger et al., “Generalized anxiety disorder: nature and course,” Journal of Clinical Psychiatry, vol. 62, no. 11, pp. 15–21, 2001.

A. A. Walf and C. A. Frye, “A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior,” Neuropsychopharmacology, vol. 31, no. 6, pp. 1097–1111, 2006.

J. Kim and J. Gorman, “The psychobiology of anxiety,” Clinical Neuroscience Research, vol. 4, no. 5-6, pp. 335–347, 2005.

M. A. Kheirbek, K. C. Klemenhagen, A. Sahay, and R. Hen, “Neurogenesis and generalization: a new approach to stratify and treat anxiety disorders,” Nature Neuroscience, vol. 15, no. 12, pp. 1613–1620, 2012.

J.-M. Revest, D. Dupret, M. Koehl et al., “Adult hippocampal neurogenesis is involved in anxiety-related behaviors,” Molecular Psychiatry, vol. 14, no. 10, pp. 959–967, 2009.

M. Chan, C. Chow, D. K. Hamson, S. E. Lieblich, and L. A. M. Galea, “Effects of chronic oestradiol, progesterone and medroxyprogesterone acetate on hippocampal neurogenesis and adrenal mass in adult female rats,” Journal of Neuroendocrinology, vol. 26, no. 6, pp. 386–399, 2014.

R. E. S. McClure, C. K. Barha, and L. A. M. Galea, “17β-Estradiol, but not estrone, increases the survival and activation of new neurons in the hippocampus in response to spatial memory in adult female rats,” Hormones and Behavior, vol. 63, no. 1, pp. 144–157, 2013.

C. A. Mazzucco, S. E. Lieblich, B. I. Bingham, M. A. Williamson, V. Viau, and L. A. M. Galea, “Both estrogen receptor α and estrogen receptor β agonists enhance cell proliferation in the dentate gyrus of adult female rats,” Neuroscience, vol. 141, no. 4, pp. 1793–1800, 2006.

P. Tanapat, N. B. Hastings, A. J. Reeves, and E. Gould, “Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat,” The Journal of Neuroscience, vol. 19, no. 14, pp. 5792–5801, 1999.

C.-S. Chen, Y.-T. Tseng, Y.-Y. Hsu, and Y.-C. Lo, “Nrf2-keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells,” Neuroendocrinology, vol. 97, no. 3, pp. 232–241, 2013.

A. A. Walf and C. A. Frye, “Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats,” Pharmacology Biochemistry and Behavior, vol. 86, no. 2, pp. 407–414, 2007.

A. A. Walf and C. A. Frye, “Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model,” Gender Medicine, vol. 6, no. 1, pp. 300–311, 2009.

A. A. Walf and C. A. Frye, “Estradiol reduces anxiety- and depression-like behavior of aged female mice,” Physiology and Behavior, vol. 99, no. 2, pp. 169–174, 2010.

M. Sárvári, L. Deli, P. Kocsis et al., “Estradiol and isotype-selective estrogen receptor agonists modulate the mesocortical dopaminergic system in gonadectomized female rats,” Brain Research, vol. 1583, no. 1, pp. 1–11, 2014.

C. Nasuti, M. Carloni, D. Fedeli et al., “Effect of 17β-estradiol on striatal dopaminergic transmission induced by permethrin in early childhood rats,” Chemosphere, vol. 112, pp. 496–502, 2014.

S. Benmansour, J. P. Piotrowski, A. V. Altamirano, and A. Frazer, “Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine,” Neuropsychopharmacology, vol. 34, no. 3, pp. 555–564, 2009.

R. B. Gibbs, D. Nelson, and R. Hammond, “Role of GPR30 in mediating estradiol effects on acetylcholine release in the hippocampus,” Hormones and Behavior, vol. 66, no. 2, pp. 339–345, 2014.

G. Patki, F. H. Allam, F. Atrooz et al., “Grape powder intake prevents ovariectomy-induced anxiety-like behavior, memory impairment and high blood pressure in female Wistar rats,” PLoS ONE, vol. 8, no. 9, Article ID e74522, 2013.

J. Simpson and J. P. Kelly, “An investigation of whether there are sex differences in certain behavioural and neurochemical parameters in the rat,” Behavioural Brain Research, vol. 229, no. 1, pp. 289–300, 2012.

J. Luo, T. Wang, S. Liang, X. Hu, W. Li, and F. Jin, “Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats,” Behavioral and Brain Functions, vol. 9, no. 1, article 46, 2013.

M. A. Wilson, P. R. Burghardt, K. A. Ford, M. B. Wilkinson, and S. D. Primeaux, “Anxiolytic effects of diazepam and ethanol in two behavioral models: comparison of males and females,” Pharmacology Biochemistry and Behavior, vol. 78, no. 3, pp. 445–458, 2004.

H. C. Atkinson and B. J. Waddell, “Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: Sexual dimorphism and changes across the estrous cycle,” Endocrinology, vol. 138, no. 9, pp. 3842–3848, 1997.

L. F. Vendruscolo, G. S. Izídio, R. N. Takahashi, and A. Ramos, “Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats,” Behavioural Pharmacology, vol. 19, no. 1, pp. 21–27, 2008.

D. A. León Rodríguez and Z. Dueñas, “Maternal separation during breastfeeding induces gender-dependent changes in anxiety and the GABA-A receptor alpha-subunit in adult Wistar rats,” PLoS ONE, vol. 8, no. 6, Article ID e68010, 2013.

G. E. Fenton, A. K. Pollard, D. M. Halliday, R. Mason, T. W. Bredy, and C. W. Stevenson, “Persistent prelimbic cortex activity contributes to enhanced learned fear expression in females,” Learning and Memory, vol. 21, no. 2, pp. 55–60, 2014.

C. A. Orsini, J. H. Kim, E. Knapska, and S. Maren, “Hippocampal and prefrontal projections to the basal amygdala mediate contextual regulation of fear after extinction,” Journal of Neuroscience, vol. 31, no. 47, pp. 17269–17277, 2011.

F. Sotres-Bayon, D. Sierra-Mercado, E. Pardilla-Delgado, and G. J. Quirk, “Gating of fear in prelimbic cortex by hippocampal and amygdala inputs,” Neuron, vol. 76, no. 4, pp. 804–812, 2012.

M. R. Milad, R. K. Pitman, C. B. Ellis et al., “Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder,” Biological Psychiatry, vol. 66, no. 12, pp. 1075–1082, 2009.

J. Altman and G. D. Das, “Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats,” Journal of Comparative Neurology, vol. 124, no. 3, pp. 319–335, 1965.

B. Lacar, S. L. Parylak, K. C. Vadodaria, A. Sarkar, and F. H. Gage, “Increasing the resolution of the adult neurogenesis picture,” F1000Prime Reports, vol. 6, article 8, 2014.

C. D. Fowler, Y. Liu, and Z. Wang, “Estrogen and adult neurogenesis in the amygdala and hypothalamus,” Brain Research Reviews, vol. 57, no. 2, pp. 342–351, 2008.

Y. Mu, S. W. Lee, and F. H. Gage, “Signaling in adult neurogenesis,” Current Opinion in Neurobiology, vol. 20, no. 4, pp. 416–423, 2010.

J. B. Aimone, Y. Li, S. W. Lee, G. D. Clemenson, W. Deng, and F. H. Gage, “Regulation and function of adult neurogenesis: from genes to cognition,” Physiological Reviews, vol. 94, no. 4, pp. 991–1026, 2014.

A. Sah, C. Schmuckermair, S. B. Sartori et al., “Anxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior,” Translational Psychiatry, vol. 2, article e171, 2012.

C. Mirescu and E. Gould, “Stress and adult neurogenesis,” Hippocampus, vol. 16, no. 3, pp. 233–238, 2006.

A. Surget, M. Saxe, S. Leman et al., “Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal,” Biological Psychiatry, vol. 64, no. 4, pp. 293–301, 2008.

D. X. Yu, M. C. Marchetto, and F. H. Gage, “How to make a hippocampal dentate gyrus granule neuron,” Development, vol. 141, no. 12, pp. 2366–2375, 2014.

M. Loi, S. Koricka, P. J. Lucassen, and M. Joëls, “Age- and sex-dependent effects of early life stress on hippocampal neurogenesis,” Frontiers in Endocrinology, vol. 5, article 13, 2014.

K. Jin, M. Minami, J. Q. Lan et al., “Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4710–4715, 2001.

H. van Praag, A. F. Schinder, B. R. Christle, N. Toni, T. D. Palmer, and F. H. Gage, “Functional neurogenesis in the adult hippocampus,” Nature, vol. 415, no. 6875, pp. 1030–1034, 2002.

L. Cao, X. Jiao, D. S. Zuzga et al., “VEGF links hippocampal activity with neurogenesis, learning and memory,” Nature Genetics, vol. 36, no. 8, pp. 827–835, 2004.

H. van Praag, G. Kempermann, and F. H. Gage, “Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus,” Nature Neuroscience, vol. 2, no. 3, pp. 266–270, 1999.

T. Murphy, G. P. Dias, and S. Thuret, “Effects of diet on brain plasticity in animal and human studies: mind the gap,” Neural Plasticity, vol. 2014, Article ID 563160, 32 pages, 2014.

J. C. Brenes, M. Lackinger, G. U. Höglinger, G. Schratt, R. K. Schwarting, and M. Wöhr, “Differential effects of social and physical environmental enrichment on brain plasticity, cognition, and ultrasonic communication in rats,” Journal of Comparative Neurology, 2015.

V. Lemaire, S. Lamarque, M. Le Moal, P.-V. Piazza, and D. N. Abrous, “Postnatal stimulation of the pups counteracts prenatal stress-induced deficits in hippocampal neurogenesis,” Biological Psychiatry, vol. 59, no. 9, pp. 786–792, 2006.

J. L. Bizon and M. Gallagher, “Production of new cells in the rat dentate gyrus over the lifespan: relation to cognitive decline,” European Journal of Neuroscience, vol. 18, no. 1, pp. 215–219, 2003.

G. P. Dias, R. Hollywood, M. C. D. N. Bevilaqua et al., “Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms,” Neuro-Oncology, vol. 16, no. 4, pp. 476–492, 2014.

J. Lee, W. Duan, and M. P. Mattson, “Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice,” Journal of Neurochemistry, vol. 82, no. 6, pp. 1367–1375, 2002.

M. F. Anderson, M. A. I. Åberg, M. Nilsson, and P. S. Eriksson, “Insulin-like growth factor-I and neurogenesis in the adult mammalian brain,” Developmental Brain Research, vol. 134, no. 1-2, pp. 115–122, 2002.

K. Deisseroth and R. C. Malenka, “GABA excitation in the adult brain: a mechanism for excitation-neurogenesis coupling,” Neuron, vol. 47, no. 6, pp. 775–777, 2005.

K. Deisseroth, S. Singla, H. Toda, M. Monje, T. D. Palmer, and R. C. Malenka, “Excitation-neurogenesis coupling in adult neural stem/progenitor cells,” Neuron, vol. 42, no. 4, pp. 535–552, 2004.

L. A. M. Galea, “Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents,” Brain Research Reviews, vol. 57, no. 2, pp. 332–341, 2008.

A. Borsini, P. A. Zunszain, S. Thuret, and C. M. Pariante, “The role of inflammatory cytokines as key modulators of neurogenesis,” Trends in Neurosciences, vol. 38, no. 3, pp. 145–157, 2015.

A. J. Eisch, H. A. Cameron, J. M. Encinas, L. A. Meltzer, G.-L. Ming, and L. S. Overstreet-Wadiche, “Adult neurogenesis, mental health, and mental illness: hope or hype?” Journal of Neuroscience, vol. 28, no. 46, pp. 11785–11791, 2008.

D. Dupret, J.-M. Revest, M. Koehl et al., “Spatial relational memory requires hippocampal adult neurogenesis,” PLoS ONE, vol. 3, no. 4, Article ID e1959, 2008.

C. Dalla, E. B. Papachristos, A. S. Whetstone, and T. J. Shors, “Female rats learn trace memories better than male rats and consequently retain a greater proportion of new neurons in their hippocampi,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2927–2932, 2009.

J. R. Epp, C. Chow, and L. A. M. Galea, “Hippocampus-dependent learning influences hippocampal neurogenesis,” Frontiers in Neuroscience, vol. 7, article 57, 2013.

D. Petrik, D. C. Lagace, and A. J. Eisch, “The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building?” Neuropharmacology, vol. 62, no. 1, pp. 21–34, 2012.

I. Mendez-David, R. Hen, A. M. Gardier, and D. J. David, “Adult hippocampal neurogenesis: an actor in the antidepressant-like action,” Annales Pharmaceutiques Francaises, vol. 71, no. 3, pp. 143–149, 2013.

S. Ge, C.-H. Yang, K.-S. Hsu, G.-L. Ming, and H. Song, “A critical period for enhanced synaptic plasticity in newly generated neurons of the adult brain,” Neuron, vol. 54, no. 4, pp. 559–566, 2007.

C. A. Blaiss, T.-S. Yu, G. Zhang et al., “Temporally specified genetic ablation of neurogenesis impairs cognitive recovery after traumatic brain injury,” The Journal of Neuroscience, vol. 31, no. 13, pp. 4906–4916, 2011.

P. J. Clark, W. J. Brzezinska, M. W. Thomas, N. A. Ryzhenko, S. A. Toshkov, and J. S. Rhodes, “Intact neurogenesis is required for benefits of exercise on spatial memory but not motor performance or contextual fear conditioning in C57BL/6J mice,” Neuroscience, vol. 155, no. 4, pp. 1048–1058, 2008.

G. P. Dias, M. C. D. N. Bevilaqua, A. C. D. S. Da Luz et al., “Hippocampal biomarkers of fear memory in an animal model of generalized anxiety disorder,” Behavioural Brain Research, vol. 263, pp. 34–45, 2014.

M. A. Kheirbek and R. Hen, “Add neurons, subtract anxiety,” Scientific American, vol. 311, no. 1, pp. 62–67, 2014.

Z. Peng, R. Zhang, H. Wang et al., “Ziprasidone ameliorates anxiety-like behaviors in a rat model of PTSD and up-regulates neurogenesis in the hippocampus and hippocampus-derived neural stem cells,” Behavioural Brain Research, vol. 244, pp. 1–8, 2013.

L. A. M. Galea, S. R. Wainwright, M. M. Roes, P. Duarte-Guterman, C. Chow, and D. K. Hamson, “Sex, hormones and neurogenesis in the hippocampus: hormonal modulation of neurogenesis and potential functional implications,” Journal of Neuroendocrinology, vol. 25, no. 11, pp. 1039–1061, 2013.

C. Barth, A. Villringer, and J. Sacher, “Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods,” Frontiers in Neuroscience, vol. 9, article 37, 2015.

C. K. Barha and L. A. M. Galea, “Influence of different estrogens on neuroplasticity and cognition in the hippocampus,” Biochimica et Biophysica Acta—General Subjects, vol. 1800, no. 10, pp. 1056–1067, 2010.

Y. Cheng, Q. Su, B. Shao et al., “17β-Estradiol attenuates poststroke depression and increases neurogenesis in female ovariectomized rats,” BioMed Research International, vol. 2013, Article ID 392434, 10 pages, 2013.

G. K. Mak, E. K. Enwere, C. Gregg et al., “Male pheromone-stimulated neurogenesis in the adult female brain: possible role in mating behavior,” Nature Neuroscience, vol. 10, no. 8, pp. 1003–1011, 2007.

B. Leuner, E. R. Glasper, and E. Gould, “Sexual experience promotes adult neurogenesis in the hippocampus despite an initial elevation in stress hormones,” PLoS ONE, vol. 5, no. 7, Article ID e11597, 2010.

L. Liu, L. Zhao, H. She et al., “Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo,” Endocrinology, vol. 151, no. 12, pp. 5782–5794, 2010.

J. M. Barker and L. A. M. Galea, “Repeated estradiol administration alters different aspects of neurogenesis and cell death in the hippocampus of female, but not male, rats,” Neuroscience, vol. 152, no. 4, pp. 888–902, 2008.

J. M. Bowers, J. Waddell, and M. M. McCarthy, “A developmental sex difference in hippocampal neurogenesis is mediated by endogenous oestradiol,” Biology of Sex Differences, vol. 1, no. 1, article 8, 2010.

C. Westenbroek, J. A. Den Boer, M. Veenhuis, and G. J. Ter Horst, “Chronic stress and social housing differentially affect neurogenesis in male and female rats,” Brain Research Bulletin, vol. 64, no. 4, pp. 303–308, 2004.

J. L. Pawluski, S. Brummelte, C. K. Barha, T. M. Crozier, and L. A. M. Galea, “Effects of steroid hormones on neurogenesis in the hippocampus of the adult female rodent during the estrous cycle, pregnancy, lactation and aging,” Frontiers in Neuroendocrinology, vol. 30, no. 3, pp. 343–357, 2009.

M. Perez-Martin, V. Salazar, C. Castillo et al., “Estradiol and soy extract increase the production of new cells in the dentate gyrus of old rats,” Experimental Gerontology, vol. 40, no. 5, pp. 450–453, 2005.

B. K. Ormerod, T. T.-Y. Lee, and L. A. M. Galea, “Estradiol enhances neurogenesis in the dentate gyri of adult male meadow voles by increasing the survival of young granule neurons,” Neuroscience, vol. 128, no. 3, pp. 645–654, 2004.

M. Banasr, M. Hery, J. M. Brezun, and A. Daszuta, “Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus,” European Journal of Neuroscience, vol. 14, no. 9, pp. 1417–1424, 2001.

H. J. Hulshof, A. Novati, P. G. M. Luiten, J. A. den Boer, and P. Meerlo, “Despite higher glucocorticoid levels and stress responses in female rats, both sexes exhibit similar stress-induced changes in hippocampal neurogenesis,” Behavioural Brain Research, vol. 234, no. 2, pp. 357–364, 2012.

P. Tanapat, N. B. Hastings, and E. Gould, “Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a dose- and time-dependent manner,” Journal of Comparative Neurology, vol. 481, no. 3, pp. 252–265, 2005.

J. M. Barker and L. A. M. Galea, “Males show stronger contextual fear conditioning than females after context pre-exposure,” Physiology & Behavior, vol. 99, no. 1, pp. 82–90, 2010.

M. D. Spritzer and L. A. M. Galea, “Testosterone and dihydrotestosterone, but not estradiol, enhance survival of new hippocampal neurons in adult male rats,” Developmental Neurobiology, vol. 67, no. 10, pp. 1321–1333, 2007.

M. Martini, L. Calandreau, M. Jouhanneau, S. Mhaouty-Kodja, and M. Keller, “Perinatal exposure to methoxychlor enhances adult cognitive responses and hippocampal neurogenesis in mice,” Frontiers in Behavioral Neuroscience, vol. 8, article 202, 2014.

C. D. Mandyam, E. F. Crawford, A. J. Eisen, C. L. Rivier, and H. N. Richardson, “Stress experienced in utero reduces sexual dichotomies in neurogenesis, microenvironment, and cell death in the adult rat hippocampus,” Developmental Neurobiology, vol. 68, no. 5, pp. 575–589, 2008.

A. R. Zuena, J. Mairesse, P. Casolini et al., “Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats,” PLoS ONE, vol. 3, no. 5, Article ID e2170, 2008.

T. J. Shors, J. Mathew, H. M. Sisti, C. Edgecomb, S. Beckoff, and C. Dalla, “Neurogenesis and helplessness are mediated by controllability in males but not in females,” Biological Psychiatry, vol. 62, no. 5, pp. 487–495, 2007.

E. M. Falconer and L. A. M. Galea, “Sex differences in cell proliferation, cell death and defensive behavior following acute predator odor stress in adult rats,” Brain Research, vol. 975, no. 1-2, pp. 22–36, 2003.

A. Klomp, L. Václavů, G. F. Meerhoff, L. Reneman, and P. J. Lucassen, “Effects of chronic fluoxetine treatment on neurogenesis and tryptophan hydroxylase expression in adolescent and adult rats,” PLoS ONE, vol. 9, no. 5, Article ID e97603, 2014.

G. E. Hodes, L. Yang, J. Van Kooy, J. Santollo, and T. J. Shors, “Prozac during puberty: distinctive effects on neurogenesis as a function of age and sex,” Neuroscience, vol. 163, no. 2, pp. 609–617, 2009.

C. A. Oomen, C. E. N. Girardi, R. Cahyadi et al., “Opposite effects of early maternal deprivation on neurogenesis in male versus female rats,” PLoS ONE, vol. 4, no. 1, Article ID e3675, 2009.

D. Suri, V. Veenit, A. Sarkar et al., “Early stress evokes age-dependent biphasic changes in hippocampal neurogenesis, BDNF expression, and cognition,” Biological Psychiatry, vol. 73, no. 7, pp. 658–666, 2013.

E. F. G. Naninck, L. Hoeijmakers, N. Kakava-Georgiadou et al., “Chronic early life stress alters developmental and adult neurogenesis and impairs cognitive function in mice,” Hippocampus, vol. 25, no. 3, pp. 309–328, 2015.

C. A. Oomen, H. Soeters, N. Audureau et al., “Early maternal deprivation affects dentate gyrus structure and emotional learning in adult female rats,” Psychopharmacology, vol. 214, no. 1, pp. 249–260, 2011.

M. Vythilingam, C. Heim, J. Newport et al., “Childhood trauma associated with smaller hippocampal volume in women with major depression,” The American Journal of Psychiatry, vol. 159, no. 12, pp. 2072–2080, 2002.

F. K. Marcondes, F. J. Bianchi, and A. P. Tanno, “Determination of the estrous cycle phases of rats: some helpful considerations,” Brazilian Journal of Biology, vol. 62, no. 4, pp. 609–614, 2002.

M. Molina-Hernández, N. P. Téllez-Alcántara, J. I. Olivera-López, and M. T. Jaramillo, “Estrous cycle variation in anxiolytic-like effects of topiramate in Wistar rats in two animal models of anxiety-like behavior,” Pharmacology Biochemistry and Behavior, vol. 103, no. 3, pp. 631–636, 2013.

M. G. Vilela, J. L. S. Júnior, and J. G. C. Silva, “Determinação do ciclo estral em ratas por lavado vaginal,” Femina, vol. 35, no. 10, pp. 667–670, 2012.

J. M. Barker and L. A. M. Galea, “Sex and regional differences in estradiol content in the prefrontal cortex, amygdala and hippocampus of adult male and female rats,” General and Comparative Endocrinology, vol. 164, no. 1, pp. 77–84, 2009.

C. Chow, J. R. Epp, S. E. Lieblich, C. K. Barha, and L. A. M. Galea, “Sex differences in neurogenesis and activation of new neurons in response to spatial learning and memory,” Psychoneuroendocrinology, vol. 38, no. 8, pp. 1236–1250, 2013.

G. Kempermann, H. G. Kuhn, and F. H. Gage, “More hippocampal neurons in adult mice living in an enriched environment,” Nature, vol. 386, no. 6624, pp. 493–495, 1997.

B. M. M. Monteiro, F. A. Moreira, A. R. Massensini, M. F. D. Moraes, and G. S. Pereira, “Enriched environment increases neurogenesis and improves social memory persistence in socially isolated adult mice,” Hippocampus, vol. 24, no. 2, pp. 239–248, 2014.

G. P. Dias, N. Cavegn, A. Nix et al., “The role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxiety,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 541971, 18 pages, 2012.

S. Thuret, N. Toni, S. Aigner, G. W. Yeo, and F. H. Gage, “Hippocampus-dependent learning is associated with adult neurogenesis in MRL/MpJ mice,” Hippocampus, vol. 19, no. 7, pp. 658–669, 2009.

A. C. Deslandes, “Exercise and mental health: what did we learn in the last 20 years?” Frontiers in Psychiatry, vol. 5, article 66, 2014.

S. Dubreucq, M. Koehl, D. N. Abrous, G. Marsicano, and F. Chaouloff, “CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis,” Experimental Neurology, vol. 224, no. 1, pp. 106–113, 2010.

M. C. Lee, K. Inoue, M. Okamoto et al., “Voluntary resistance running induces increased hippocampal neurogenesis in rats comparable to load-free running,” Neuroscience Letters, vol. 537, pp. 6–10, 2013.

E. M. M. Portugal, T. Cevada, R. S. Monteiro-Junior et al., “Neuroscience of exercise: from neurobiology mechanisms to mental health,” Neuropsychobiology, vol. 68, no. 1, pp. 1–14, 2013.

A. Deslandes, H. Moraes, C. Ferreira et al., “Exercise and mental health: many reasons to move,” Neuropsychobiology, vol. 59, no. 4, pp. 191–198, 2009.

R. B. Speisman, A. Kumar, A. Rani, T. C. Foster, and B. K. Ormerod, “Daily exercise improves memory, stimulates hippocampal neurogenesis and modulates immune and neuroimmune cytokines in aging rats,” Brain, Behavior, and Immunity, vol. 28, pp. 25–43, 2013.

C. H. Duman, L. Schlesinger, D. S. Russell, and R. S. Duman, “Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice,” Brain Research, vol. 1199, pp. 148–158, 2008.

J. N. Salam, J. H. Fox, E. M. DeTroy, M. H. Guignon, D. F. Wohl, and W. A. Falls, “Voluntary exercise in C57 mice is anxiolytic across several measures of anxiety,” Behavioural Brain Research, vol. 197, no. 1, pp. 31–40, 2009.

E. Binder, S. K. Droste, F. Ohl, and J. M. H. M. Reul, “Regular voluntary exercise reduces anxiety-related behaviour and impulsiveness in mice,” Behavioural Brain Research, vol. 155, no. 2, pp. 197–206, 2004.

T. Nishijima, M. Llorens-Martín, G. S. Tejeda et al., “Cessation of voluntary wheel running increases anxiety-like behavior and impairs adult hippocampal neurogenesis in mice,” Behavioural Brain Research, vol. 245, pp. 34–41, 2013.

J. Fuss, N. M.-B. Ben Abdallah, M. A. Vogt et al., “Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis,” Hippocampus, vol. 20, no. 3, pp. 364–376, 2010.

M. M. Onakomaiya, D. M. Porter, J. G. Oberlander, and L. P. Henderson, “Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse,” Hormones and Behavior, vol. 66, no. 2, pp. 283–297, 2014.

D. Stangl and S. Thuret, “Impact of diet on adult hippocampal neurogenesis,” Genes and Nutrition, vol. 4, no. 4, pp. 271–282, 2009.

M. S. A. Zainuddin and S. Thuret, “Nutrition, adult hippocampal neurogenesis and mental health,” British Medical Bulletin, vol. 103, no. 1, pp. 89–114, 2012.

Á. Fontán-Lozano, G. López-Lluch, J. M. Delgado-García, P. Navas, and Á. M. Carrión, “Molecular bases of caloric restriction regulation of neuronal synaptic plasticity,” Molecular Neurobiology, vol. 38, no. 2, pp. 167–177, 2008.

M. C. Riddle, M. C. McKenna, Y. J. Yoon et al., “Caloric restriction enhances fear extinction learning in mice,” Neuropsychopharmacology, vol. 38, no. 6, pp. 930–937, 2013.

R. Kenny, T. Dinan, G. Cai, and S. J. Spencer, “Effects of mild calorie restriction on anxiety and hypothalamic-pituitary-adrenal axis responses to stress in the male rat,” Physiological Reports, vol. 2, no. 3, Article ID e00265, 2014.

J. Lee, K. B. Seroogy, and M. P. Mattson, “Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice,” Journal of Neurochemistry, vol. 80, no. 3, pp. 539–547, 2002.

Á. Fontán-Lozano, J. L. Sáez-Cassanelli, M. C. Inda et al., “Caloric restriction increases learning consolidation and facilitates synaptic plasticity through mechanisms dependent on NR2B subunits of the NMDA receptor,” Journal of Neuroscience, vol. 27, no. 38, pp. 10185–10195, 2007.

V. R. Venna, D. Deplanque, C. Allet, K. Belarbi, M. Hamdane, and R. Bordet, “PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus,” Psychoneuroendocrinology, vol. 34, no. 2, pp. 199–211, 2009.

W. O. Ogle, R. B. Speisman, and B. K. Ormerod, “Potential of treating age-related depression and cognitive decline with nutraceutical approaches: a mini-review,” Gerontology, vol. 59, no. 1, pp. 23–31, 2013.

S. J. Kim, T. G. Son, H. R. Park et al., “Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus,” The Journal of Biological Chemistry, vol. 283, no. 21, pp. 14497–14505, 2008.

F. Allam, A. T. Dao, G. Chugh et al., “Grape powder supplementation prevents oxidative stress-induced anxiety-like behavior, memory impairment, and high blood pressure in rats,” Journal of Nutrition, vol. 143, no. 6, pp. 835–842, 2013.

J. A. Shin, S. Oh, J.-H. Ahn, and E.-M. Park, “Estrogen receptor-mediated resveratrol actions on blood-brain barrier of ovariectomized mice,” Neurobiology of Aging, vol. 36, no. 2, pp. 993–1006, 2015.

H. Hirase and Y. Shinohara, “Transformation of cortical and hippocampal neural circuit by environmental enrichment,” Neuroscience, vol. 280, pp. 282–298, 2014.

K. Takuma, Y. Ago, and T. Matsuda, “Preventive effects of an enriched environment on rodent psychiatric disorder models,” Journal of Pharmacological Sciences, vol. 117, no. 2, pp. 71–76, 2011.

P. Rohlfs Domínguez, “Promoting our understanding of neural plasticity by exploring developmental plasticity in early and adult life,” Brain Research Bulletin, vol. 107, pp. 31–36, 2014.

P. Leal-Galicia, A. Saldívar-González, S. Morimoto, and C. Arias, “Exposure to environmental enrichment elicits differential hippocampal cell proliferation: role of individual responsiveness to anxiety,” Developmental Neurobiology, vol. 67, no. 4, pp. 395–405, 2007.

H. Okuda, K. Tatsumi, M. Makinodan, T. Yamauchi, T. Kishimoto, and A. Wanaka, “Environmental enrichment stimulates progenitor cell proliferation in the amygdala,” Journal of Neuroscience Research, vol. 87, no. 16, pp. 3546–3553, 2009.

R. J. Kotloski and T. P. Sutula, “Environmental enrichment: evidence for an unexpected therapeutic influence,” Experimental Neurology, vol. 264, pp. 121–126, 2015.

S. Nicolas, J. Veyssière, C. Gandin et al., “Neurogenesis-independent antidepressant-like effects of enriched environment is dependent on adiponectin,” Psychoneuroendocrinology, vol. 57, pp. 72–83, 2015.

M. Leger, E. Paizanis, K. Dzahini et al., “Environmental enrichment duration differentially affects behavior and neuroplasticity in adult mice,” Cerebral Cortex, vol. 25, no. 11, pp. 4048–4061, 2015.

B. B. Sherwin, “Estrogen effects on cognition in menopausal women,” Neurology, vol. 48, no. 5, supplement 7, pp. S21–S26, 1997.

B. B. Sherwin, “Can estrogen keep you smart? Evidence from clinical studies,” Journal of Psychiatry & Neuroscience, vol. 24, no. 4, pp. 315–321, 1999.

C. A. Frye, M. E. Rhodes, and B. Dudek, “Estradiol to aged female or male mice improves learning in inhibitory avoidance and water maze tasks,” Brain Research, vol. 1036, no. 1-2, pp. 101–108, 2005.

A. A. Walf, C. J. Koonce, and C. A. Frye, “Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice,” Behavioral Neuroscience, vol. 122, no. 5, pp. 974–981, 2008.

W. A. Koss, D. R. Gehlert, and A. Shekhar, “Different effects of subchronic doses of 17-β estradiol in two ethologically based models of anxiety utilizing female rats,” Hormones and Behavior, vol. 46, no. 2, pp. 158–164, 2004.

Y. Dong, A. Jiang, H. Yang, H. Chen, and Y. Wang, “Phytoestrogen alpha-zearalanol improves memory impairment and hippocampal neurogenesis in ovariectomized mice,” The Scientific World Journal, vol. 2014, Article ID 862019, 6 pages, 2014.

L. Prokai, V. Nguyen, S. Szarka et al., “The prodrug DHED selectively delivers 17beta-estradiol to the brain for treating estrogen-responsive disorders,” Science Translational Medicine, vol. 7, no. 297, Article ID 297ra113, 2015.

D. J. Toufexis, K. M. Myers, and M. Davis, “The effect of gonadal hormones and gender on anxiety and emotional learning,” Hormones and Behavior, vol. 50, no. 4, pp. 539–549, 2006.

M. Sárvári, I. Kalló, E. Hrabovszky et al., “Hippocampal gene expression is highly responsive to estradiol replacement in middle-aged female rats,” Endocrinology, vol. 156, no. 7, pp. 2632–2645, 2015.

D. M. Bannerman, J. N. P. Rawlins, S. B. McHugh et al., “Regional dissociations within the hippocampus—memory and anxiety,” Neuroscience and Biobehavioral Reviews, vol. 28, no. 3, pp. 273–283, 2004.

M. Bergami, R. Rimondini, S. Santi, R. Blum, M. Götz, and M. Canossa, “Deletion of TrkB in adult progenitors alters newborn neuron integration into hippocampal circuits and increases anxiety-like behavior,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 40, pp. 15570–15575, 2008.

A. C. Campos, G. N. Vaz, V. M. Saito, and A. L. Teixeira, “Further evidence for the role of interferon-gamma on anxiety- and depressive-like behaviors: involvement of hippocampal neurogenesis and NGF production,” Neuroscience Letters, vol. 578, pp. 100–105, 2014.

D. J. David, B. A. Samuels, Q. Rainer et al., “Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression,” Neuron, vol. 62, no. 4, pp. 479–493, 2009.

H. Ageta, A. Murayama, R. Migishima et al., “Activin in the brain modulates anxiety-related behavior and adult neurogenesis,” PLoS ONE, vol. 3, no. 4, Article ID e1869, 2008.

P. M. Wise, “Estrogens: protective or risk factors in brain function?” Progress in Neurobiology, vol. 69, no. 3, pp. 181–191, 2003.

K. Holzschneider and C. Mulert, “Neuroimaging in anxiety disorders,” Dialogues in Clinical Neuroscience, vol. 13, no. 4, pp. 453–461, 2011.

P. S. Eriksson, E. Perfilieva, T. Björk-Eriksson et al., “Neurogenesis in the adult human hippocampus,” Nature Medicine, vol. 4, no. 11, pp. 1313–1317, 1998.

K. L. Spalding, O. Bergmann, K. Alkass et al., “Dynamics of hippocampal neurogenesis in adult humans,” Cell, vol. 153, no. 6, pp. 1219–1227, 2013.